USP8 and non-small cell lung carcinoma: Additionally, we also examined whether the USP8 inhibitor combination with PD-L1 blockade could suppress tumor growth in the autochthonous non-small cell lung cancers (NSCLC) of KrasLSL-G12D/+Tp53fl/fl (KP) mice model.